The PI3K/AKT/mTOR pathway is altered in many human cancers, including breast and ovarian cancers, and has been extensively studied as a target for anticancer therapies for many years.13, 14, 15, 16, 17. The gene discussed is PIK3CA; the disease is ovarian cancer.